Winscene Technology key facts
as of Oct 2026- Developer and manufacturer of light and heat curing functional materials designed for advanced manufacturing industry.
- Winscene Technology is valued at approximately $152.7M as of Oct 2026 (last reported valuation).
- It has raised $27.5M; the latest was Later Stage VC ($13.8M) in May 2025.
- Notable investors include Korea Investment Partners, Sky9 Capital, Shanghai Guohe Capital, Jinshan Capital Group, Beijing Singularity Power Investment Fund — 11 tracked in total.
- Status: Privately Held (backing).
Winscene Technology's last reported valuation, Sep 2024. Nothing priced has surfaced since.
- ·The complete investor list: 11 names
- ·Watch Winscene Technology: the Monday email on marks, rounds and moves
Winscene Technology funding rounds
No funding rounds for Winscene Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Winscene Technology
11+Winscene Technology valuation
Winscene Technology's last reported valuation was $153 million in Sep 2024. No priced round, secondary trade or fund mark has surfaced since.
Winscene Technology investors
11 investors are on record for Winscene Technology, including Korea Investment Partners, Sky9 Capital, Shanghai Guohe Capital and Jinshan Capital Group.
About Winscene Technology
Developer and manufacturer of light and heat curing functional materials designed for advanced manufacturing industry. The company's products include photosensitive dielectric materials, optical adhesives, lithographic polyimide and other products, which are mainly used in 5G optical communication, new display, advanced semiconductor packaging and other industries, providing industrial users with high-quality special material solutions.
- Sector
- Business Products and Services (B2B)
- HQ
- Shanghai, China
- Founded
- 2019
- Website
- winscene.com.cn/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.